Guillain-Barre Syndrome Secondary to the Use of Dabrafenib and Trametinib for the Treatment of Advanced Thyroid Carcinoma

BRAF V600E mutation in thyroid malignancies is associated with an aggressive phenotype with more rapid tumor growth and higher mortality. V600E is a driver mutation in the BRAF proto-oncogene, where valine (V) is substituted by glutamic acid (E) at amino acid 600. New chemotherapeutic agents targeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Jaskaran, Ankireddypalli, Anvitha, Kanugula, Ashok K, Gorle, Swathi, Kaur, Jasleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937682/
https://www.ncbi.nlm.nih.gov/pubmed/36819948
http://dx.doi.org/10.7759/cureus.35069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937682/
https://www.ncbi.nlm.nih.gov/pubmed/36819948
http://dx.doi.org/10.7759/cureus.35069

Ejemplares similares